What is Avantor's bioscience & medtech products — net sales?

Avantor (AVTR) reported bioscience & medtech products — net sales of $431.4M in Q1 2026.

What does bioscience & medtech products — net sales mean?

This metric represents the total revenue generated from the sale of products and services specifically within the Bioscience and Medtech business segment. It serves as a primary indicator of market demand and the company's ability to capture value within the biopharma and healthcare sectors.

Avantor AVTR Bioscience & Medtech Products — Net Sales

Other segment segments

VWR Distribution & Services

$1.15B—

Similar metrics at other companies

IFFHealth & Biosciences — Net Sales

$595M+10.2%

BAXMedical Products & Therapies — Net Sales

$1.29B+1.8%

GLW

GLWLife Science Products — Net Sales

$228M0.0%

BIOLife Science — Net Sales

$228.5M0.0%

DCILife Sciences Segment — Net Sales

$83.5M+12.5%

IEXHealth & Science Technologies — Net Sales

$398.4M+16.7%

Other financials

Income statement

See full

Revenue$1.6B0.0%

Gross profit$500.7M-6.4%

Operating income$99.5M-32.5%

Net income$43.3M-32.9%

EPS (diluted)$0.06-33.3%

Balance sheet

See full

Cash & equivalents$282.2M-11.4%

Total debt$3.8B-7.1%

Total equity$5.6B-8.4%

Total assets$11.7B-5.4%

Cash flow

See full

Operating cash flow$58.7M-46.3%

CapEx$33.5M+19.6%

Free cash flow$25.2M-69.0%

Valuation

See full

Market cap$6.54B-52.0%

Enterprise value$10.07B-40.4%

P/S1×-1.0×

Profitability

See full

Gross margin32.1%-1.4pp

Operating margin4%-5.2pp

Net margin-9.2%-19.9pp

FCF margin6.7%-3.3pp

Returns & leverage

See full

Return on equity-10.3%-22.8pp

Debt / equity0.7×0.0×

Current ratio1.8×+0.6×

Where this comes from

Reported directly by Avantor in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Avantor’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avantor's bioscience & medtech products — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Avantor's bioscience & medtech products — net sales?: Avantor (AVTR) reported bioscience & medtech products — net sales of $431.4M in Q1 2026.
What does bioscience & medtech products — net sales mean?: This metric represents the total revenue generated from the sale of products and services specifically within the Bioscience and Medtech business segment. It serves as a primary indicator of market demand and the company's ability to capture value within the biopharma and healthcare sectors.